Immunoprotein Diagnostic Testing Market To Reach $14.86 Billion By 2030

Immunoprotein Diagnostic Testing Market Growth & Trends

The global immunoprotein diagnostic testing market size is estimated to reach USD 14.86 billion in 2030 and is projected to grow at a CAGR of 7.7% from 2024 to 2030. This growth can be attributed to the rising incidence of chronic diseases.

According to American Heart Association’s 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected to rise in order to facilitate rapid diagnosis.

According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.

Technological advancements in the field of immunoprotein diagnostics have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.

 Request a free sample copy or view report summary: Immunoprotein Diagnostic Testing Market Report

Immunoprotein Diagnostic Testing Market Report Highlights

• Infectious disease testing held largest market share in 2023 owing to the increasing prevalence of infectious diseases and high applications of immunoprotein tests

• Enzyme-based immunoassays dominated the market in 2023 due to their frequent usage and availability of large number of products that possess this technology

• Chemiluminescence assay is anticipated to witness highest growth over the forecast period due to its high sensitivity and specificity

• North America dominated the market in 2023 due to rising prevalence of cancer & increase in mortality due to cancer-related diseases and favorable healthcare reimbursement scenario in the U.S.

Immunoprotein Diagnostic Testing Market Segmentation

Grand View Research has segmented the global immunoprotein diagnostic testing market report based on test, technology, material, fluid, application and region

Immunoprotein Diagnostic Testing Test Outlook (Revenue, USD Million, 2018 - 2030)

• Complement System Proteins Diagnostic Tests

• Free Light Chain Diagnostic Tests

• Haptoglobin Diagnostic Tests

• Immunoglobulin Diagnostic Tests

• Prealbumin Diagnostic Tests

• C-Reactive Protein (CRP) Diagnostic Tests

Immunoprotein Diagnostic Testing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Infectious Disease Testing 

• Oncology Testing

• Endocrine Testing

• Toxicology Testing

• Allergy Testing

• Autoimmune Disease Testing

Immunoprotein Diagnostic Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Radioimmunoassay

• Enzyme Based Immunoassay

• Chemiluminescence Assay

• Immunofluorescence Assay

• Immunoturbidity Assay

• Immunoprotein Electrophoresis

Immunoprotein Diagnostic Testing End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals and Clinics

• Diagnostic Laboratories

• Others

Immunoprotein Diagnostic Testing Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Direct Tender

• Retail Sales

Immunoprotein Diagnostic Testing Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Immunoprotein Diagnostic Testing Market

• Agilent Technologies, Inc.

• Danaher Corporation

• Thermo Fisher Scientific Inc.

• PerkinElmer Inc.

• Bio-Rad Laboratories, Inc.

• Aurora Biomed Inc.

• Tecan Trading AG

• Promega Corporation

• Charles River Laboratories

• Creative Biolabs.